Latest News in the pharma Industry

All

NousCom raises €42 million to develop off-the-shelf cancer vaccine

NousCom raises €42 million to develop off-the-shelf cancer vaccine

6 Nov 2017

Financing to advance its pipeline of neoantigen cancer-based immunotherapies to the clinic.

Read more 
FDA approves Zelboraf for Erdheim-Chester Disease

FDA approves Zelboraf for Erdheim-Chester Disease

6 Nov 2017

Zelboraf is the first FDA-approved treatment for Erdheim-Chester disease ECD, a rare blood disease.

Read more 
Venezuela’s emerging pharmaceutical markets threatened

Venezuela’s emerging pharmaceutical markets threatened

5 Nov 2017

Economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers.

Read more 
RA patients treated with baricitinib reported greater improvements in pain compared with adalimumab

RA patients treated with baricitinib reported greater improvements in pain compared with adalimumab

5 Nov 2017

Post-hoc analysis shows pain improvement was consistent regardless of a patient's baseline pain severity.

Read more 
Celonic acquires Glycotope’s biomanufacturing facility

Celonic acquires Glycotope’s biomanufacturing facility

3 Nov 2017

Combined technology assets will provides pharmaceutical and biotech customers the unique opportunity to select a tailored expression system.

Read more 
Bio-Kult Infantis scoops Best Mother & Baby Care Product 2017!

Bio-Kult Infantis scoops Best Mother & Baby Care Product 2017!

3 Nov 2017

Bio-Kult Infantis receives Best Mother and Baby Care Product Award in the Natural Pharmacy Business Awards 2017!

Natural Pharmacy Business is the UK’s leading natural pharmacy trade magazine, dedicated to growing pharmacists' knowledge of natu...

Read more 
RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

2 Nov 2017

Rizaport is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines.

Read more 
Mylan response to announcement of proposed amendments to civil complaint

Mylan response to announcement of proposed amendments to civil complaint

2 Nov 2017

Company says it has found "no evidence of price fixing on the part of Mylan or its employees".

Read more 
Novartis announces planned acquisition of Advanced Accelerator Applications

Novartis announces planned acquisition of Advanced Accelerator Applications

2 Nov 2017

Acquisition would add Lutathera, a first-in-class RadioLigand Therapy approved in Europe and under review in the US for neuroendocrine tumours.

Read more 
Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

Cristal Therapeutics progresses nanomedicine CriPec-docetaxel to Phase Ib development

1 Nov 2017

This nanomedicine candidate is specifically designed to enable enhanced tumour accumulation and local drug release at the target site, to boost the therapeutic efficacy and to overcome the shortfalls associated with current docetaxel products.

Read more 
Normon Laboratories selects TraceLink to comply with EU FMD

Normon Laboratories selects TraceLink to comply with EU FMD

1 Nov 2017

TraceLink selected for its demonstrated EU and country compliance capabilities and enterprise scalability.

Read more 
Reig Jofre's nutritional supplements line expands its product portfolio

Reig Jofre's nutritional supplements line expands its product portfolio

1 Nov 2017

Forté Pharma expands its energy and health segments with the launch of eight references in the French market, as a result of its product development strategy.

Read more